Activin and Inhibin

CBB1007 trihydrochloride is a cell-permeable amidino-guanidinium compound that acts as a potent, reversible and substrate competitive LSD1 selective inhibitor (IC50 = 5.27 μM for hLSD1).IC50 Value: 5.27 uMTarget: hLSD1CBB1007 efficiently can block

CBB1007 trihydrochloride is a cell-permeable amidino-guanidinium compound that acts as a potent, reversible and substrate competitive LSD1 selective inhibitor (IC50 = 5.27 μM for hLSD1).IC50 Value: 5.27 uMTarget: hLSD1CBB1007 efficiently can block

CBB1007 trihydrochloride is a cell-permeable amidino-guanidinium compound that acts as a potent, reversible and substrate competitive LSD1 selective inhibitor (IC50 = 5.27 μM for hLSD1).IC50 Value: 5.27 uMTarget: hLSD1CBB1007 efficiently can block

CBB1007 trihydrochloride is a cell-permeable amidino-guanidinium compound that acts as a potent, reversible and substrate competitive LSD1 selective inhibitor (IC50 = 5.27 μM for hLSD1).IC50 Value: 5.27 uMTarget: hLSD1CBB1007 efficiently can block

Cbl-b-IN-1 (example 519) is a Cbl-b inhibitor, extracted from patent WO2019148005A1, with an IC 50 &lt:100 nMForm:SolidIC50&amp: Target:IC50: &lt:100 nM (Cbl-b).

Cbl-b-IN-1 (example 519) is a Cbl-b inhibitor, extracted from patent WO2019148005A1, with an IC 50 &lt:100 nMForm:SolidIC50&amp: Target:IC50: &lt:100 nM (Cbl-b).

Cbl-b-IN-1 (example 519) is a Cbl-b inhibitor, extracted from patent WO2019148005A1, with an IC 50 &lt:100 nMForm:SolidIC50&amp: Target:IC50: &lt:100 nM (Cbl-b).

Cbl-b-IN-1 (example 519) is a Cbl-b inhibitor, extracted from patent WO2019148005A1, with an IC 50 &lt:100 nMForm:SolidIC50&amp: Target:IC50: &lt:100 nM (Cbl-b).

Cbl-b-IN-1 (example 519) is a Cbl-b inhibitor, extracted from patent WO2019148005A1, with an IC 50 &lt:100 nMForm:SolidIC50&amp: Target:IC50: &lt:100 nM (Cbl-b).

Cbl-b-IN-1 (example 519) is a Cbl-b inhibitor, extracted from patent WO2019148005A1, with an IC 50 &lt:100 nMIC50&amp: Target:IC50: &lt:100 nM (Cbl-b).

Cbl-b-IN-3 (Compound 23) is a casitas B-lineage lymphoma proto-oncogene-b ( Cbl-b ) inhibitor with an IC 50 of &lt: 1 nM. Cbl-b is an E3 ubiquitin ligase that negatively regulates T-cell activationIn VitroCbl-b-IN-3 (Compound 23) enhances IL-2

Cbl-b-IN-3 (Compound 23) is a casitas B-lineage lymphoma proto-oncogene-b ( Cbl-b ) inhibitor with an IC 50 of &lt: 1 nM. Cbl-b is an E3 ubiquitin ligase that negatively regulates T-cell activationIn VitroCbl-b-IN-3 (Compound 23) enhances IL-2